PDGFB and neoplasm: Single-Cell RNA-Seq reveals that the TAMs of PDGFB-driven proneural tumors is dominated by microglia and PLX3397 treatment can remodels the TAMs in this type of tumor by downregulating pro-tumor gene expression, leading to a favorable response to PLX3397 therapy.